Related Experiment Video
Updated: Sep 19, 2025

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
Published on: June 15, 2019
New Model of Integrated Care for Patients with Immune-Mediated Inflammatory Diseases
Esther Chamorro-de-Vega1,2, C M González2,3, L Menchén2,4
1Pharmacy Department-CEIMI, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Introduction:
The complexity and transversality of the care for patients with immune-mediated inflammatory diseases (IMIDs) represents a challenge for the usual structure of health care services and requires a transformation of existing clinical management models. We describe the design, implementation and evaluation of a new collaborative care model for patients with IMIDs.
Description:
A group of multidisciplinary professionals including specialists from the rheumatology, gastroenterology, dermatology and pharmacy services designed and implemented an innovative health care model for patients with IMIDs that has changed the traditional model of care. One of the main challenges is the transversal leadership system in collaboration with all the hospital services involved, including the Medical Directorate of the hospital and patients, which promotes greater responsibility and empowerment.
Discussion:
Although IMID patient care by a multidisciplinary team is widely recommended, guidelines for IMID-specific models are lacking and few authors have reported controversial results of this strategy.
Conclusions:
CEIMI is a pioneering collaborative and multidisciplinary care model for patients with immune-mediated inflammatory diseases. This new model is integrated by physicians, pharmacists and specialised nurses and is oriented to meet the needs and expectations of the patients.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Chronic Kidney Disease III: Interprofessional Care
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...

